Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.

Avant Technologies Proposes Acquisition of Ainnova Tech to Consolidate Vision AI JV

May 13, 2025

Healthcare Services

Avant Technologies has entered formal negotiations to acquire its joint-venture partner Ainnova Tech (operating through Ai-nova Acquisition Corp.), aiming to merge the businesses ahead of an FDA pre-submission meeting. The deal is intended to streamline regulatory coordination, speed clinical development and support U.S. market entry for the Vision AI clinical screening platform currently piloted across Latin America.

Novo Integrated Sciences Acquires Clinical Consultants International LLC

March 23, 2022

Healthcare Services

Novo Integrated Sciences (NASDAQ: NVOS) has acquired Clinical Consultants International LLC (CCI) in an all-stock transaction, completing the purchase in April 2022. CCI, a Boca Raton–based global healthcare consulting firm led by Dr. Joseph M. Chalil, will see Dr. Chalil appointed Chief Medical Officer of Novo and President of Novomerica Health Group to expand Novo's healthcare capabilities and market entry services.

ANI Pharmaceuticals Acquires Novitium Pharma for $163.5M

March 9, 2021

Pharmaceuticals

ANI Pharmaceuticals completed the acquisition of Novitium Pharma for $163.5 million (including $89.5M cash and $74M equity, plus up to $46.5M in contingent earn-outs), adding a U.S.-based R&D engine and CDMO manufacturing capacity. The deal, financed with a new $300M Term Loan B, a $40M revolver and a $25M PIPE investment from Ampersand Capital Partners, is expected to be immediately accretive and expand ANI's generics, contract manufacturing and 505(b)(2) capabilities.

Novo Holdings Acquires Altasciences from Audax Private Equity

February 22, 2021

Healthcare Services

Novo Holdings has agreed to acquire Altasciences, a Laval, Canada–headquartered contract research and CDMO services provider, from Audax Private Equity. Altasciences— which operates six facilities across the U.S. and Canada and employs over 1,300 people—will remain led by CEO Chris Perkin and is expected to continue expanding domestically and internationally under Novo Holdings' ownership.

Nicox S.A. Acquires Aciex Therapeutics, Inc.

July 2, 2014

Pharmaceuticals

Nicox S.A. agreed to acquire Aciex Therapeutics, Inc., a U.S.-based ophthalmic development company, in a share-exchange deal that will transfer 100% of Aciex to Nicox. The transaction (approved by Nicox shareholders on October 22, 2014) issues 20,627,024 new Nicox shares for Aciex equity and includes contingent value rights giving up to $55 million in potential additional consideration tied to FDA approvals, and is intended to broaden Nicox's ophthalmic development pipeline.

Netezza Acquires NuTech Solutions

May 15, 2008

Data & Analytics

Netezza Corporation acquired NuTech Solutions, a Charlotte-based provider of predictive analytics and optimization solutions, adding roughly 30 analytic scientists and engineers and their intellectual property. NuTech will operate as an independent division of Netezza, extending Netezza's advanced analytics capabilities across automotive, consumer goods, energy and government verticals.